Side by side

1. 1.TB-500, a thymosin beta-4 fragment, is studied for cell migration in animal repair models.
2. 2.BPC-157 is proposed to work through VEGFR2 and nitric-oxide signalling in animal wound models.
3. 3.KPV, a three-amino-acid fragment of alpha-MSH, is studied for anti-inflammatory effects on melanocortin receptors in cell and animal work.
4. 4.GHK-Cu, a copper-binding tripeptide, is studied for collagen synthesis and wound repair in laboratory models.
5. 5.Stacking assumes complementary pathways, but there is no pharmacokinetic or safety work on the mixture, and the peptides could interact unpredictably.

• Tendon and connective-tissue repair claims
• Skin healing and scarring claims
• Gut inflammation claims, from the KPV component
• No combination has been studied in humans

• Reported improvements in skin and recovery from user accounts
• Laboratory effects of the individual peptides on collagen and inflammation
• No measured clinical effect for the blend

• Injection-site irritation
• Possible copper-related effects with GHK-Cu at high exposure
• Headache, nausea and flushing reported
• No combination safety data exist

Research context only — no approved or studied protocol exists. Community schedules use about 15 syringe units daily from a vial reconstituted with 3 ml of bacteriostatic water; because the unit count depends on the exact concentrations in that particular vial, it cannot be copied from one product to another. No cycle length has been evaluated.

Research context only